Evidation Health’s $45 Million Series D Financing


Fenwick & West represented Evidation Health in the transaction.

Evidation Health, a health data analytics platform provider, completed its $45 million Series D financing. B Capital Group led the round, which includes new investors McKesson Ventures and Section 32 as well as existing investors Revelation Partners, Rethink Impact and SV Health Investors.

This round of funding will help Evidation power the expansion of its privacy-first, direct-to-person research platform, Achievement, to include virtual health. The company will use this new capital to build upon its existing evidence generation capabilities to offer real-time insights and digital tools to its network of nearly 4 million individuals.

Evidation measures health in everyday life and enables anyone to participate in ground-breaking research and health programs. Built upon a foundation of user privacy and control over permissioned health data, Evidation’s Achievement platform is trusted by millions of individuals—generating data with unprecedented speed, scale, and rigor. Founded in 2012, Evidation Health is headquartered in California with additional offices around the globe.

The Fenwick transaction team representing Evidation Health included corporate partner Michael Esquivel (Picture), associates Ryan McRobert and Noah Johnson, and law clerk Sarah Hill.

Involved fees earner: Michael Esquivel – Fenwick & West LLP; Noah Johnson – Fenwick & West LLP; Ryan McRobert – Fenwick & West LLP;

Law Firms: Fenwick & West LLP;

Clients: Evidation Health, Inc.;

Author: Ambrogio Visconti